In this special 2-part episode, Drs. Nicos Labropoulos and Bret Wiechmann join The PVD Channel for an illuminating journey, from initial evaluation and appropriate therapies, to an in-depth examination of the intravascular imaging modalities that can make a positive impact on treatment for deep venous disease.
Part I – Initial Evaluation and Therapy of Patients with Combined Superficial and Deep Venous Disease
In Part I, The PVD Channel is pleased to welcome Nicos Labropoulos, PhD for a closer look at proper evaluation and therapy for patients with combined superficial and deep venous disease. Join Dr. Labropoulos as he shares his personal experiences and data-driven recommendations for optimal disease identification and evaluation, as well as patient management. Focusing on treating the superficial veins, Dr. Labropoulos explains how we can treat these veins while avoiding adverse outcomes in deep venous disease, helping to improve our patients’ overall prognoses.
Part II – Intravascular Imaging in Deep Venous Disease
In Part II, Bret Wiechmann, MD lends his Vascular and Interventional Radiology expertise to The PVD Channel for a detailed assessment of intravascular imaging in deep venous disease. Join Dr. Wiechmann for an evaluation of technological and scientific advances – including challenging, real-world cases – and learn how the evolution of intravascular imaging has rendered IVUS the gold standard, including the ways in which IVUS can help our patients achieve improved results.
After completing this activity, the participant should be better able to:
- Identify the signs and symptoms of venous obstruction
- Recognize iliac vein obstruction via IVUS imaging
- Select the optimal imaging modality at each stage of deep venous disease
The educational design of this activity addresses the needs of Interventional Radiologists, Vascular Surgeons, Vascular Specialists, Nurse Practitioners, Radiologic Technologists, and Vascular Allied Health Professionals involved in the treatment of patients with peripheral vascular disease.
Nicos Labropoulos, PhD, RVT
Professor of Surgery and Radiology
Director, Vascular Laboratory
Department of Surgery
Stony Brook University Hospital
Stony Brook, NY, USA
Dr. Nicos Labropoulos is a professor of Surgery and Radiology and the Director of the Vascular Laboratory at Stony Brook University Hospital in Long Island, NY.
Dr. Labropoulos completed his undergraduate training at the University of London and his PhD and Vascular Fellowship at St. Mary’s Hospital, Imperial College of Science Technology and Medicine, London, UK.
Dr. Labropoulos has been awarded multiple grants for clinical and basic science studies, many prizes in medical and surgical meetings around the world and has been a traveling fellow of the Royal Society of Medicine.
He is actively involved in many national and international vascular and venous societies as well as national committees and accrediting organizations. He serves on the editorial board of 11 journals and is a reviewer for over 20 medical and surgical journals. He has more than 300 publications, has been cited over 15000 times and has given over 1200 presentations around the world. He has edited 5 vascular textbooks and has contributed over 60 book chapters on the diagnosis and management of vascular diseases.
He has been working on vascular imaging, aortic wall remodeling, cerebrovascular disease, and the development and natural history of chronic venous disorders and venous thromboembolism including the inflammatory pathways in both. He served on the Panel of VTE Experts at the Joint Commission and the National Quality Forum and is a recipient of the Society of Vascular Surgery’s Presidential Citation Award and UIP Gold Medal award of excellence for clinical research in Phlebology. He is also actively involved in vascular training and education through many local, national, and international organizations and has organized numerous vascular meetings. Dr. Labropoulos is a co-founder of the International Vascular Foundation, the Institute of Vascular Diseases, and the Venous Health Foundation.
Bret N. Wiechmann, MD, FSIR, FAHA, FSVM
Vascular & Interventional Physicians
Doctors Imaging Group
Gainesville, FL, USA
Dr. Bret Wiechmann has been in private practice for 24 years with Vascular & Interventional Physicians, with a particular interest in peripheral arterial disease and critical limb ischemia, abdominal aortic aneurysms, carotid intervention, and venous disease. He has been elected a Fellow by the Society of Interventional Radiology, the Society of Vascular Medicine, the American Heart Association, and the Outpatient Endovascular & Interventional Society (OEIS).
Dr. Wiechmann has given over 190 invited lectures and has been principal investigator for numerous clinical trials in peripheral arterial intervention, carotid stenting, medical therapy for PAD, and stem cell therapy for critical limb ischemia. Dr. Wiechmann is a founding member of the Outpatient Endovascular & Interventional Society (OEIS), serves on the Board, and is currently President-elect. Dr. Wiechmann’s practice includes six interventional radiologists and has been involved with the treatment of arterial and venous disorders for a number of years, both hospital-based and at the office-based lab, which opened in 2006.
Physician Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and Educational Awareness Solutions. Global is accredited by the ACCME to provide continuing medical education for physicians.
Physician Credit Designation
Global Education Group designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM MOC Recognition Statement
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 medical knowledge MOC point in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Nurse Practitioner Continuing Education
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of Global Education Group and Educational Awareness Solutions. Global Education Group is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 110121. This activity is approved for 1.0 contact hour(s) (which includes 0.0 hour(s) of pharmacology).
American Society of Radiologic Technologists
This activity has been reviewed and approved for 1.0 Category A CE credit by the ASRT.
European Board for Accreditation in Cardiology
This programme is accredited by the European Board for Accreditation of Continuing Education for Health Professionals (EBAC) for 1.0 hour(s) of external CE credit(s). Each participant should claim only those hours of credit that have actually been spent in the educational activity.
Term of Offering
This activity was released on May 15, 2022 and is valid for one year. Requests for credit must be made no later than June 1, 2023.
Global Contact Information
For information about the accreditation of this program, please contact Global at 303-395-1782 or firstname.lastname@example.org.
Instructions to Receive Credit
In order to receive credit for this activity, the participant must complete the pre-activity questions, view the program in its entirety, and complete the post-activity questions, evaluation form, and credit request.
Fee Information and Refund/Cancellation Policy
There is no fee for this educational activity.
Disclosure of Conflicts of Interest
Global Education Group (Global) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months to Global. All financial relationships reported are identified as relevant and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure objectivity and that the activity is free of commercial bias.
In compliance with EBAC guidelines, all speakers/chairpersons participating in this programme have disclosed or indicated potential conflicts of interest which might cause a bias in the presentations. The Organizing Committee/Course Director is responsible for ensuring that all potential conflicts of interest relevant to the event are declared to the audience prior to the CE activities.
All relevant financial relationships have been mitigated.
The faculty have the following relevant financial relationships with ineligible companies:
Name of Faculty or Presenter
|Reported Financial Relationship
|Nicos Labropoulos, PhD, RVT
||Honoraria: BD Bard, Boston Scientific, Philips, Sun Scientific
Bret N. Weichmann, MD, FSIR, FAHA, FSVM
|Consulting Fees: Boston Scientific, BD Bard, Philips, Veryan Medical, AngioDynamics
The planners and managers have the following relevant financial relationships with ineligible companies:
Contracted Research: Vesper Medical, Philips, Medtronic, Boston Scientific
Speaker’s Bureau: Philips, Cook Medical, Medtronic, Boston Scientific
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and Educational Awareness Solutions do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
An Internet-connected web browser is required.